ArticlePediatric research2026
Hippo signaling pathway regulates branching morphogenesis of the fetal lung under hypoxia.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypoxia is known to disrupt embryonic organogenesis and increase the risk of neonatal respiratory disorders. The Hippo pathway is crucial in regulating organ development, size, and cell proliferation. However, the mechanism of how hypoxia affects lung development through this pathway remains unclear.
methodsFetal lungs were dissected from embryonic day 11.5 ICR mice and cultured ex vivo under normoxic (21% O₂) or hypoxic (1% O₂) conditions for 72 h, while human fetal lung fibroblasts (IMR-90) were exposed for 24 h. RNA sequencing analysis was performed on mouse fetal lungs. Biochemical analyses of lactate dehydrogenase and interleukin-6 were performed on supernatants. Expression levels of Hippo pathway-related proteins were determined by Western blot and immunofluorescence.
resultsHypoxia markedly inhibited branching morphogenesis, reducing terminal bronchioles and total lung area (p < 0.05). Elevated LDH and IL-6 levels indicated cytotoxicity and inflammation. Western blot analysis revealed increased phosphorylation of YAP/TAZ, accompanied by decreased SOX2 expression (p < 0.05). Furthermore, genes related to cell differentiation and adhesion were also downregulated, indicating disrupted epithelial-mesenchymal coordination.
conclusionThese findings suggest that hypoxia may alter Hippo signaling in fetal lung fibroblasts, thereby impairing branching morphogenesis. Prenatal hypoxia exposure might contribute to abnormal lung development and increase susceptibility to neonatal pulmonary disorders. IMPACT: Prenatal hypoxia impairs fetal lung branching morphogenesis by modulating Hippo signaling and fibroblast-derived factors. Prenatal hypoxia enhances cytotoxicity and inflammatory cytokine production in fetal lungs and fibroblasts. This study provides new insights into the pathogenesis of hypoxia-related neonatal lung disorders and suggests Hippo signaling as a potential therapeutic target.
Identifiers
42020796What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.